PT Maja Agung Latexindo Tbk (IDX:SURI)
Indonesia · Delayed Price · Currency is IDR 126.00
-7.00 (-5.26%)
Aug 28, 2025, 4:14 PM WIB
IDX:SURI Revenue
PT Maja Agung Latexindo Tbk had revenue of 36.22B IDR in the quarter ending June 30, 2025, with 211.15% growth. This brings the company's revenue in the last twelve months to 148.51B, up 34.49% year-over-year. In the year 2024, PT Maja Agung Latexindo Tbk had annual revenue of 116.67B with 42.77% growth.
Revenue (ttm)
148.51B
Revenue Growth
+34.49%
P/S Ratio
5.67
Revenue / Employee
1.04B
Employees
143
Market Cap
842.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 116.67B | 34.95B | 42.77% |
| Dec 31, 2023 | 81.72B | -11.61B | -12.44% |
| Dec 31, 2022 | 93.33B | -244.80B | -72.40% |
| Dec 31, 2021 | 338.13B | 24.75B | 7.90% |
| Dec 31, 2020 | 313.37B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 3,202.64B |
| PT Kalbe Farma Tbk. | 33.38T |
| PT Mitra Keluarga Karyasehat Tbk | 4,985.33B |
| PT Siloam International Hospitals Tbk | 12.30T |
| PT Medikaloka Hermina Tbk | 6,761.48B |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3,851.30B |
| PT Tempo Scan Pacific Tbk | 13.48T |
| PT Metro Healthcare Indonesia Tbk | 311.61B |